Loading stock analysis…
Evidence Synthesis
Last synthesized: 11 Jul 2026, 05:09
Evidence Synthesis
JBCHEPHARM's 67.77% accelerated to 80% from 16.48%, up from 25.29%, in the latest quarterly update.
The company's .8% accelerated to 80% from -31%, up from 25.29%, in the latest quarterly update. JBCHEPHARM's .5 INR accelerated to 80% from 2435.8 INR, up from 25.29%, in the latest daily update.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 67.77 % | 16.48 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 16.48 % | 17.11 | ▼ |
| REVENUE_GROWTH_YOY | -4.8 % | -31 | ▲ |
| EPS_ACTUAL | 12.75 INR | 13.08 | ▼ |
| EPS_SURPRISE_PERCENT | -0.063 % | 0.014 | ▼ |
| PRICE_CHANGE_PERCENT | 0.357 % | — | - |
| DAILY_VOLUME | 2,15,586 shares | 3,22,437 | ▼ |
| CLOSE_PRICE | 2,444.5 INR | 2,435.8 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.78 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 2 count | 5 | ▼ |
| TARGET_PRICE_PREMIUM | -7.44 % | — | - |